Perrigo Co. Plc (PRGO)

51.69
0.13 0.25
NYSE : Health Technology
Prev Close 51.56
Open 51.71
Day Low/High 51.52 / 51.91
52 Wk Low/High 36.28 / 80.66
Volume 80.23K
Avg Volume 1.19M
Exchange NYSE
Shares Outstanding 135.99M
Market Cap 6.99B
EPS 0.90
P/E Ratio 60.48
Div & Yield 0.84 (1.55%)
Insider Trading Alert - HAFC, ALKS And PRGO Traded By Insiders

Insider Trading Alert - HAFC, ALKS And PRGO Traded By Insiders

Stocks with insider trader activity include HAFC, ALKS and PRGO

You Can Be Data Dependent, Too

You Can Be Data Dependent, Too

The Fed isn't the only one that can use facts in shaping decisions.

Perrigo (PRGO) Stock: Weak On High Volume Today

Perrigo (PRGO) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Perrigo (PRGO) as a weak on high relative volume candidate

Analysts' Actions -- Express Scripts, Expedia, Perrigo, WellCare and More

Analysts' Actions -- Express Scripts, Expedia, Perrigo, WellCare and More

Here are Monday's top research calls, including downgrades for Express Scripts, Expedia and Perrigo, and several upgrades for WellCare.

19 Charts to Calm Your Recession Fears

19 Charts to Calm Your Recession Fears

Is it better to choose stocks through fundamental or technical analysis? Real Money's Bruce Kamich puts his technical spin on these recession-proof stocks chosen by Morgan Stanley analysts.

AZN, PRGO And VRX, 3 Drugs Stocks Pushing The Industry Lower

AZN, PRGO And VRX, 3 Drugs Stocks Pushing The Industry Lower

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Today's Unusual Social Activity Stock: Perrigo (PRGO)

Today's Unusual Social Activity Stock: Perrigo (PRGO)

Trade-Ideas LLC identified Perrigo (PRGO) as an unusual social activity candidate

Wells Fargo Says Sell Valeant As Philidor Questions Remain Unanswered

Wells Fargo Says Sell Valeant As Philidor Questions Remain Unanswered

The shares of Valeant Pharmaceuticals are falling after Wells Fargo initiated coverage of the stock with an Underperform rating, the firm's equivalent of a "Sell."

Perrigo (PRGO) Stock Price Target Cut at Jefferies

Perrigo (PRGO) Stock Price Target Cut at Jefferies

Jefferies decreased its price target on Perrigo (PRGO) stock and maintained its ‘buy’ rating.

Dinged Perrigo Presents Prime Opportunity

Dinged Perrigo Presents Prime Opportunity

Its best entry points over the last nine years looked very similar to the company's current valuation.

Virtual Reality Hype Carries Nvidia to Top of S&P 500 off Earnings Beat

Excitement surrounding 3D-technology appears to be paying off for Nvidia.

Perrigo (PRGO) Stock Plunges on Earnings Miss

Perrigo (PRGO) Stock Plunges on Earnings Miss

Perrigo (PRGO) stock is sinking in mid-morning trading on Thursday after the company reported lower-than-expected 2015 fourth quarter results.

Perrigo (PRGO) Lagging In Pre-Market Activity

Perrigo (PRGO) Lagging In Pre-Market Activity

Trade-Ideas LLC identified Perrigo (PRGO) as a pre-market laggard candidate

19 Stocks You Should Own if the U.S. Falls Into a Recession

19 Stocks You Should Own if the U.S. Falls Into a Recession

As speculation mounts that the U.S. economy will enter a recession, here are 19 stocks you should own just in case.

Generic Drug ETF Offering Portfolio Cure

Generic Drug ETF Offering Portfolio Cure

With biotech stocks getting smashed on the stock market and big pharma getting hammered on the presidential campaign trail, generic drug stocks look awfully appealing.

5 Toxic Stocks to Sell as the Market Rolls Over

5 Toxic Stocks to Sell as the Market Rolls Over

It's time to unload these toxic stocks from your portfolio.

Perrigo (PRGO) Marked As Today's Post-Market Laggard

Perrigo (PRGO) Marked As Today's Post-Market Laggard

Trade-Ideas LLC identified Perrigo (PRGO) as a post-market laggard candidate

Perrigo (PRGO): Stock With Unusual Social Activity

Perrigo (PRGO): Stock With Unusual Social Activity

Trade-Ideas LLC identified Perrigo (PRGO) as an unusual social activity candidate

Perrigo (PRGO) Stock Gets ‘Overweight’ Rating at Barclays

Perrigo (PRGO) Stock Gets ‘Overweight’ Rating at Barclays

Barclays began coverage of Perrigo (PRGO) stock with an ‘overweight’ rating and $180 price target on Thursday morning.

Deutsche Bank Recommends These 8 Health Care Stocks on Market Volatility

Deutsche Bank Recommends These 8 Health Care Stocks on Market Volatility

Investors should stick with sectors that were leaders in 2015 such as health care and technology, according to Deutsche Bank. Here are eight health care stocks to consider.

Perrigo (PRGO) Showing Signs Of Being Water-Logged And Getting Wetter

Perrigo (PRGO) Showing Signs Of Being Water-Logged And Getting Wetter

Trade-Ideas LLC identified Perrigo (PRGO) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

3 Health Care Stocks Moving The Sector Upward

3 Health Care Stocks Moving The Sector Upward

TheStreet highlights 3 stocks pushing the health care sector higher today.

Perrigo (PRGO) Shows Signs Of Being Water-Logged And Getting Wetter

Perrigo (PRGO) Shows Signs Of Being Water-Logged And Getting Wetter

Trade-Ideas LLC identified Perrigo (PRGO) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Analysts' Actions -- Cummins, First Solar, Men's Wearhouse, Toll Brothers and More

Analysts' Actions -- Cummins, First Solar, Men's Wearhouse, Toll Brothers and More

Here are Thursday's top research calls, including an upgrade for Toll Brothers, and downgrades for Men's Wearhouse, First Solar and Cummins.

Deutsche Bank's 31 Large-Cap Stocks to Buy for 2016

Deutsche Bank's 31 Large-Cap Stocks to Buy for 2016

Which large-cap stocks are the best bang for your buck in 2016? Deutsche Bank has a list of 31 companies for you to consider.

Heading Back Toward Overbought Land

From the looks of things, a pullback should be easier for the market by next week.

3 Drugs Stocks Moving The Industry Upward

3 Drugs Stocks Moving The Industry Upward

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Perrigo (PRGO) Stock Declined on AstraZeneca Drug Rights Deal

Perrigo (PRGO) Stock Declined on AstraZeneca Drug Rights Deal

Perrigo (PRGO) stock closed down on Monday, after agreeing to purchase U.S. drug rights from AstraZeneca for $380 million.

China Drives Another Nail in the Coffins of GNC and Vitamin Shoppe

Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.

2 Safe and Cheap Health Care Stocks

2 Safe and Cheap Health Care Stocks

These two will continue to churn out earnings growth.

TheStreet Quant Rating: D+ (Sell)